German pharmaceuticals and chemicals company Bayer AG says it plans a separate stock listing for its polymer division.
The Leverkusen-based company that invented aspirin said Thursday the move would be part of an effort to focus the group on its health care and crop science businesses.
German news agency dpa reported that analysts have valued the polymer division at about $10 billion.
Bayer says a final decision on the listing has yet to be made.
Date: September 18, 2014
Source: Associated Press